Testing effectiveness (Phase 2)Ended earlyNCT00850499
What this trial is testing
Phase 2 Study of VELCADE With Fludarabine in Comparison to Rituximab With Fludarabine in Follicular Lymphoma Patients Previously Treated With Rituximab
Who this might be right for
Follicular Lymphoma
Millennium Pharmaceuticals, Inc. 12